Realising the potential of correlates of protection for vaccine development, licensure and use: short summary
- PMID: 38684704
- PMCID: PMC11058756
- DOI: 10.1038/s41541-024-00872-6
Realising the potential of correlates of protection for vaccine development, licensure and use: short summary
Abstract
On 27–29th of September 2022, Wellcome convened an international multi-stakeholder workshop to discuss the use of Correlates of Protection (CoP) to accelerate vaccine development, the hybrid format meeting was attended by 80 delegates including developers, manufacturers, regulators, public health officials and policy-makers from 17 countries, including 7 LMIC’s.
Conflict of interest statement
The authors have no conflicts of interest other than Frederick Wittke and Stanley Plotkin. F.W. is an Employee of MSD, acting as TA Head European Clinical Development for Vaccines, and holds shares from MSD. S.P. consults for vaccine manufacturers including pharmaceutical and biotech companies, as well as non-profit organisations.
Figures
References
-
- Immunization. https://www.who.int/news-room/facts-in-pictures/detail/immunization (2019).
-
- Vaccines and immunization. https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1 (2024).
-
- Lo AW, Siah KW, Wong CH. Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs. Harv. Data Sci. Rev. 2020 doi: 10.1162/99608f92.e0c150e8. - DOI
-
- How have Covid-19 vaccines been made quickly and safely? News, Wellcome. https://wellcome.org/news/quick-safe-covid-vaccine-development#the-usual... (2024).
Grants and funding
LinkOut - more resources
Full Text Sources